Decreases in tyrosine and p-hydroxyphenylglycol caused by various antidepressants

• Published in: Biochemical pharmacology Vol. 37; no. 10; p. 2069
• Main Authors: Edwards, D J, Sorisio, D A, Sedlock, M L
• Format: Journal Article
• Language: English
• Published: England 15.05.1988
• Subjects: Animals; Antidepressive Agents - pharmacology; Brain Chemistry - drug effects; Chlorpromazine - pharmacology; Ethylene Glycols - analysis; Male; Methoxyhydroxyphenylglycol - analogs & derivatives; Methoxyhydroxyphenylglycol - analysis; Norepinephrine - metabolism; Phenols - analysis; Rats; Rats, Inbred Strains; Receptors, Adrenergic, beta - drug effects; Tyrosine - analysis
• ISSN: 0006-2952
• DOI: 10.1016/0006-2952(88)90558-8

The effects of eleven different antidepressant drugs on brain p-hydroxyphenylglycol (pHPG) and on brain and plasma tyrosine concentrations were investigated in rats. Imipramine, amitriptyline, amoxapine, desmethylimipramine and iprindole (20 mg/kg each) and bupropion (50 mg/kg) decreased brain pHPG levels 4.5 or 6 hr after injection. Each of these drugs also significantly reduced plasma tyrosine levels 1.5 hr after injection. In contrast, zimelidine, amitriptylinoxide, trimipramine and trazodone had no significant effect on either brain pHPG or plasma tyrosine. Mianserin significantly lowered plasma tyrosine but produced a nonsignificant decrease in brain pHPG. The decreases in brain pHPG caused by the various drugs were significantly correlated with 3,4-dihydroxyphenylethyleneglycol. Moreover, decreases in brain pHPG and brain and plasma tyrosine concentrations were correlated with the potencies of these drugs to inhibit in vitro norepinephrine uptake. These results suggest the possibility that noradrenergic (or similar) mechanisms regulate both pHPG and tyrosine levels. However, the decreases in pHPG cannot be explained entirely by a deficiency in tyrosine, since the depletions in pHPG were much larger and longer lasting than those of tyrosine.